Latest Bain Capital Life Sciences Investors, LLC Stock Portfolio
Bain Capital Life Sciences Investors, LLC Performance:
2025 Q2: 3.47%YTD: -11.66%2024: 6.07%
Performance for 2025 Q2 is 3.47%, and YTD is -11.66%, and 2024 is 6.07%.
About Bain Capital Life Sciences Investors, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Bain Capital Life Sciences Investors, LLC reported an equity portfolio of $799.3 Millions as of 30 Jun, 2025.
The top stock holdings of Bain Capital Life Sciences Investors, LLC are NAMS, CDTX, NUVL. The fund has invested 24.3% of it's portfolio in NEWAMSTERDAM PHARMA COMPANY and 15.2% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off X4 PHARMACEUTICALS INC (XFOR) and NAUTILUS BIOTECHNOLOGY INC (NAUT) stocks. They significantly reduced their stock positions in DISC MEDICINE INC. Bain Capital Life Sciences Investors, LLC opened new stock positions in X4 PHARMACEUTICALS INC (XFOR). The fund showed a lot of confidence in some stocks as they added substantially to CIDARA THERAPEUTICS INC (CDTX), CABALETTA BIO INC (CABA) and UPSTREAM BIO INC.
The top stock holdings of Bain Capital Life Sciences Investors, LLC are NAMS, CDTX, NUVL. The fund has invested 24.3% of it's portfolio in NEWAMSTERDAM PHARMA COMPANY and 15.2% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off X4 PHARMACEUTICALS INC (XFOR) and NAUTILUS BIOTECHNOLOGY INC (NAUT) stocks. They significantly reduced their stock positions in DISC MEDICINE INC. Bain Capital Life Sciences Investors, LLC opened new stock positions in X4 PHARMACEUTICALS INC (XFOR). The fund showed a lot of confidence in some stocks as they added substantially to CIDARA THERAPEUTICS INC (CDTX), CABALETTA BIO INC (CABA) and UPSTREAM BIO INC.
Bain Capital Life Sciences Investors, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Bain Capital Life Sciences Investors, LLC made a return of 3.47% in the last quarter. In trailing 12 months, it's portfolio return was -10.18%.
New Buys
| Ticker | $ Bought |
|---|---|
| x4 pharmaceuticals inc | 1,071,330 |
New stocks bought by Bain Capital Life Sciences Investors, LLC
Additions
| Ticker | % Inc. |
|---|---|
| cidara therapeutics inc | 255 |
| cabaletta bio inc | 250 |
| upstream bio inc | 6.28 |
Additions to existing portfolio by Bain Capital Life Sciences Investors, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| disc medicine inc | -40.67 |
| dianthus therapeutics inc | -7.71 |
Bain Capital Life Sciences Investors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| nautilus biotechnology inc | -923,354 |
| x4 pharmaceuticals inc | -3,998,890 |
Bain Capital Life Sciences Investors, LLC got rid off the above stocks
Sector Distribution
Bain Capital Life Sciences Investors, LLC has about 78.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 78.3 |
| Others | 21.6 |
Market Cap. Distribution
Bain Capital Life Sciences Investors, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 46 |
| SMALL-CAP | 18.8 |
| MICRO-CAP | 17.4 |
| MID-CAP | 13.8 |
| NANO-CAP | 4 |
Stocks belong to which Index?
About 29.6% of the stocks held by Bain Capital Life Sciences Investors, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 70.4 |
| RUSSELL 2000 | 29.6 |
Bain Capital Life Sciences Investors, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC has 23 stocks in it's portfolio. About 87.4% of the portfolio is in top 10 stocks. NAMS proved to be the most loss making stock for the portfolio. CDTX was the most profitable stock for Bain Capital Life Sciences Investors, LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| NAMS | newamsterdam pharma company | 24.29 | 10,719,100 | 194,123,000 | unchanged | 0.00 | ||
Historical Trend of NEWAMSTERDAM PHARMA COMPANY Position Held By Bain Capital Life Sciences Investors, LLCWhat % of Portfolio is NAMS?:Number of NAMS shares held:Change in No. of Shares Held: | ||||||||
| CDTX | cidara therapeutics inc | 15.24 | 2,500,680 | 121,808,000 | added | 255 | ||
| NUVL | nuvalent inc | 13.82 | 1,447,270 | 110,426,000 | unchanged | 0.00 | ||
| PHVS | pharvaris n v | 7.27 | 3,303,380 | 58,139,500 | unchanged | 0.00 | ||
| dianthus therapeutics inc | 5.79 | 2,482,250 | 46,244,300 | reduced | -7.71 | |||
| SVRA | savara inc | 5.02 | 17,600,600 | 40,129,400 | unchanged | 0.00 | ||
| SLDB | solid biosciences inc | 4.82 | 7,911,670 | 38,529,800 | unchanged | 0.00 | ||
| disc medicine inc | 3.87 | 583,500 | 30,902,200 | reduced | -40.67 | |||
| OLMA | olema pharmaceuticals inc | 3.65 | 6,843,950 | 29,155,200 | unchanged | 0.00 | ||
| RPID | rapid micro biosystems inc | 3.64 | 8,434,560 | 29,099,200 | unchanged | 0.00 | ||
| upstream bio inc | 3.35 | 2,439,540 | 26,786,100 | added | 6.28 | |||
| CABA | cabaletta bio inc | 1.84 | 9,677,120 | 14,709,200 | added | 250 | ||
| TNGX | tango therapeutics inc | 1.74 | 2,712,010 | 13,885,500 | unchanged | 0.00 | ||
| ANNX | annexon inc | 1.58 | 5,249,070 | 12,597,800 | unchanged | 0.00 | ||
| kyverna therapeutics inc | 1.29 | 3,368,370 | 10,340,900 | unchanged | 0.00 | |||
| AVIR | atea pharmaceuticals inc | 1.12 | 2,485,640 | 8,948,300 | unchanged | 0.00 | ||
| XLO | xilio therapeutics inc | 0.39 | 4,566,820 | 3,104,980 | unchanged | 0.00 | ||
| IPSC | century therapeutics inc | 0.38 | 5,410,360 | 3,022,770 | unchanged | 0.00 | ||
| MRSN | mersana therapeutics inc | 0.32 | 346,547 | 2,564,450 | unchanged | 0.00 | ||
| CCCC | c4 therapeutics inc | 0.20 | 1,111,910 | 1,590,030 | unchanged | 0.00 | ||
